Trump's Drug Policy and U.S.-China Trade Relations

This chapter examines the political dynamics during President Trump's administration with a focus on drug policy and trade interactions with Canada, Mexico, and particularly China. It explores the complexities of Trump's trade approach amidst challenges in China’s economy, highlighting the strategic implications of tariffs and antitrust actions linked to American tech firms like Google. Additionally, it discusses the contrasting approaches of the Trump and Biden administrations in maintaining international alliances and addressing rising geopolitical tensions.